VEEV·VEEV

VEEV is currently trading at $156.56, giving VEEV a market cap of 30.39B and a P/E ratio of 35.3. Today's range spans $171.05–$177.14, with shares opening at $173.95 and moving up $0.23 (0.1%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL) with a news sentiment reading of 57/100.

Over the past year VEEV has traded between $168.13 and $310.50 - the current price is -6.9% off the 52-week low and -49.6% from the high. 40 analysts cover the stock with a Buy consensus and a mean 12-month target of $308.63 (range $215.00–$380.00), implying upside of +97.1%.

VEEV: large-cap, Healthcare, 30.39B market cap. (P/E: 35.3) Technical score 23/100 (SELL). Sentiment: neutral (57/100). Price: $156.56 (near 52-week lows). Range: $168.13–$310.50. The SELL designation at this capitalization tier doesn't mean the stock is uninvestable - it means the risk/reward of buying dips hasn't been restored yet, and patience or an outright hedge is often the better posture until technical conditions improve.

When a large-cap Healthcare name with 30.39B in capitalization prints a SELL signal (23/100) alongside neutral news sentiment (57/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $156.56 (near 52-week lows in the $168.13–$310.50 range), the structural support levels are where that sponsorship question gets answered.